Krystal Biotech, Inc.
Ticker: 1711279
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 119.22+2.5% | 116.36+19.0% | 97.80+1.8% | 96.04+8.9% | 88.18+5.2% | 83.84+19.3% | 70.28+55.3% | 45.25 |
| Total Income | 119.22+2.5% | 116.36+19.0% | 97.80+1.8% | 96.04+8.9% | 88.18+5.2% | 83.84+19.3% | 70.28+55.3% | 45.25 |
| EXPENSES | ||||||||
| Expenditure | 60.81-3.0% | 62.67+11.1% | 56.43-0.5% | 56.74+9.1% | 52.01-15.3% | 61.41-0.5% | 61.72+18.9% | 51.93 |
| Tax | 11.31+105.3% | 5.51+117.5% | -31.40-472.0% | 8.44+7.4% | 7.86+203.5% | 2.59+439.6% | 0.48 | — |
| PROFIT | ||||||||
| PBT | 66.08+7.6% | 61.44+28.1% | 47.97+2.5% | 46.78+7.3% | 43.60+46.5% | 29.77+85.5% | 16.05 | — |
| Net Profit | 54.77-2.1% | 55.93-29.5% | 79.37+107.1% | 38.33+7.3% | 35.73+31.5% | 27.18+74.6% | 15.57+1574.2% | 0.93 |
| KEY METRICS | ||||||||
| OPM % | 49.00%+2.86pp | 46.14%+3.84pp | 42.30%+1.38pp | 40.93%-0.10pp | 41.02%+14.27pp | 26.76%+14.57pp | 12.19%+26.96pp | -14.77% |
| NPM % | 45.94%-2.13pp | 48.07%-33.08pp | 81.15%+41.24pp | 39.91%-0.61pp | 40.52%+8.10pp | 32.42%+10.27pp | 22.15%+20.09pp | 2.06% |
| EPS | 1.85-3.1% | 1.91-30.3% | 2.74+106.0% | 1.33+7.3% | 1.24+30.5% | 0.95+75.9% | 0.54+1700.0% | 0.03 |
Corporate Events
Board MeetingKRYS
202615May
Board Meeting
2026 Annual Meeting of Stockholders to vote on the election …
SEC Filing ↗